Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Zhuhai Trinomab Pharmaceutical Co Days Inventory?
Zhuhai Trinomab Pharmaceutical CoSHSE:688806 -4.38%2 Days Inventory is 962.99 as of Dec. 2025, which is 2% below its 10-year median of 986.58. GuruFocus rates SHSE:688806 with a GF Score™ of 2/100. The stock has 7 warning signs investors should review. Among 920 Drug Manufacturers companies, Zhuhai Trinomab Pharmaceutical Co ranks worse than 98.7% on this metric.
The historical rank and industry rank for Zhuhai Trinomab Pharmaceutical Co's Days Inventory or its related term are showing as below:
SHSE:688806'
s Days Inventory Range Over the Past 10 Years
Min: 962.99 Med: 986.58 Max: 3043.55
Current: 962.99
During the past 4 years, Zhuhai Trinomab Pharmaceutical Co's highest Days Inventory was 3043.55. The lowest was 962.99. And the median was 986.58.
SHSE:688806's Days Inventory is ranked worse than 98.7% of 920
companies
in the Drug Manufacturers industry
Industry Median: 164.815
vs SHSE:688806: 962.99
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhuhai Trinomab Pharmaceutical Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.38.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhuhai Trinomab Pharmaceutical Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 1.49.
Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhuhai Trinomab Pharmaceutical Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhuhai Trinomab Pharmaceutical Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zhuhai Trinomab Pharmaceutical Co Days Inventory Related Terms
Zhuhai Trinomab Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhuhai Trinomab Pharmaceutical Co Days Inventory Chart
Zhuhai Trinomab Pharmaceutical Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Days Inventory
3,043.55
0.00
986.58
962.99
Zhuhai Trinomab Pharmaceutical Co Semi-Annual Data
Dec22
Dec23
Dec24
Dec25
Days Inventory
3,043.55
0.00
986.58
962.99
SHSE:688806 vs ZTS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Zhuhai Trinomab Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhuhai Trinomab Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhuhai Trinomab Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zhuhai Trinomab Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) has a Days Inventory of 962.99 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhuhai Trinomab Pharmaceutical Co and its competitors. This is near median its historical median of 986.58. Over the past decade, Zhuhai Trinomab Pharmaceutical Co's Days Inventory has ranged from 962.99 to 3,043.55. According to the industry distribution chart, Zhuhai Trinomab Pharmaceutical Co ranks #908 out of 920 companies in the Drug Manufacturers industry, placing it in the top 98.7%.
Is Zhuhai Trinomab Pharmaceutical Co's Days Inventory too high?
Zhuhai Trinomab Pharmaceutical Co's current Days Inventory of 962.99 is near median its 10-year median of 986.58. Over the past 10 years, this metric has ranged from a low of 962.99 to a high of 3,043.55. The Drug Manufacturers industry median Days Inventory is 164.82. Zhuhai Trinomab Pharmaceutical Co's value of 962.99 is 484.3% above this industry median. Based on the distribution chart, Zhuhai Trinomab Pharmaceutical Co ranks #908 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Zhuhai Trinomab Pharmaceutical Co has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Zhuhai Trinomab Pharmaceutical Co's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhuhai Trinomab Pharmaceutical Co ranks #908 out of 920 companies for Days Inventory. This places Zhuhai Trinomab Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 164.82. Zhuhai Trinomab Pharmaceutical Co's value of 962.99 is 484.3% above this benchmark. Historically, Zhuhai Trinomab Pharmaceutical Co's own Days Inventory has ranged from 962.99 to 3,043.55 over the past decade. While the company's 10-year median is 986.58 vs. the industry median of 164.82, Zhuhai Trinomab Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.82, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhuhai Trinomab Pharmaceutical Co's current Days Inventory of 962.99 is 484.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhuhai Trinomab Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhuhai Trinomab Pharmaceutical Co's current Days Inventory is 962.99, which is near median its own 10-year median of 986.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhuhai Trinomab Pharmaceutical Co stock overvalued right now?
Zhuhai Trinomab Pharmaceutical Co (SHSE:688806) has a current Days Inventory of 962.99. The current Days Inventory is 962.99, which is near median its 10-year median of 986.58 and 484.3% above the Drug Manufacturers industry median of 164.82. Zhuhai Trinomab Pharmaceutical Co's overall GF Score™ is 2/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zhuhai Trinomab Pharmaceutical Co (SHSE:688806), the current Days Inventory is 962.99 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688806 has been successfully added to your 
